Erythema Multiforme: Unveiling the Unusual Effect of an Ayurvedic Medication 'Jambavasa' Used in the Treatment of Type 2 Diabetes Mellitus.
Cutaneous Manifestations of Diabetes Mellitus: A Review.
Lima AL, Illing T, Schliemann S, Elsner P.
Am J Clin Dermatol. 2017 Aug;18(4):541-553. doi: 10.1007/s40257-017-0275-z.
Type 2 Diabetes Mellitus with Early Dry Skin Disorder: A Comparison Study Between Primary and Tertiary Care in Indonesia.
Legiawati L, Bramono K, Indriatmi W, Yunir E, Pratama AI.
Curr Diabetes Rev. 2022;18(2):e060821195350. doi: 10.2174/1573399817666210806102212.
Bloom Syndrome.
Hafsi W, Badri T, Rice AS.
2023 Jul 3. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Once-weekly albiglutide in the management of type 2 diabetes: patient considerations.
Woodward HN, Anderson SL.
Patient Prefer Adherence. 2014 May 29;8:789-803. doi: 10.2147/PPA.S53075. eCollection 2014.
Charcot osteoarthropathy in type 2 diabetes persons presenting to specialist diabetes clinic at a tertiary care hospital.
Younis BB, Shahid A, Arshad R, Khurshid S, Masood J.
BMC Endocr Disord. 2015 Jun 12;15:28. doi: 10.1186/s12902-015-0023-4.
Erythema Multiforme: Unveiling the Unusual Effect of an Ayurvedic Medication 'Jambavasa' Used in the Treatment of Type 2 Diabetes Mellitus.
Gemnani R, Mahajan S, Saboo K, Pradeep U, Gupta A.
Cureus. 2023 Aug 10;15(8):e43306. doi: 10.7759/cureus.43306. eCollection 2023 Aug.
Case report: Dupilumab treatment improved type 2 disorders in a patient with IPEX syndrome diagnosis.
Caruso C, Laterza L, Settanni CR, Colantuono S, Di Mario C, Tolusso B, Castrì F, Gremese E, Scaldaferri F, Armuzzi A, De Simone C, Peris K, Chiricozzi A, Gasbarrini A.
Front Immunol. 2023 Jan 11;13:995304. doi: 10.3389/fimmu.2022.995304. eCollection 2022.
Updates on disorders in curly hair.
Geisler AN, Taye M, Larrondo J, Mayo TT, Aguh C, McMichael A, MacKelfresh JB, Krueger L.
Int J Dermatol. 2024 Sep;63(9):1145-1154. doi: 10.1111/ijd.17184. Epub 2024 Apr 15.
Use of Flash Glucose-Sensing Technology for 12 months as a Replacement for Blood Glucose Monitoring in Insulin-treated Type 2 Diabetes.
Haak T, Hanaire H, Ajjan R, Hermanns N, Riveline JP, Rayman G.
Diabetes Ther. 2017 Jun;8(3):573-586. doi: 10.1007/s13300-017-0255-6. Epub 2017 Apr 11.
Insulin allergy in a patient with Type 2 diabetes successfully treated with continuous subcutaneous insulin infusion.
Moyes V, Driver R, Croom A, Mirakian R, Chowdhury TA.
Diabet Med. 2006 Feb;23(2):204-6. doi: 10.1111/j.1464-5491.2006.01811.x.
